The Cooper Companies, Inc. (COO)
USD 92.39
(-2.22%)
USD 92.39
(-2.22%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.35 Billion USD | 10.2% |
| 2022 | 2.13 Billion USD | 9.4% |
| 2021 | 1.95 Billion USD | 27.43% |
| 2020 | 1.53 Billion USD | -12.64% |
| 2019 | 1.75 Billion USD | 7.63% |
| 2018 | 1.63 Billion USD | 19.51% |
| 2017 | 1.36 Billion USD | 16.43% |
| 2016 | 1.17 Billion USD | 9.61% |
| 2015 | 1.07 Billion USD | -1.95% |
| 2014 | 1.09 Billion USD | 6.31% |
| 2013 | 1.02 Billion USD | 11.13% |
| 2012 | 924.01 Million USD | 14.81% |
| 2011 | 804.8 Million USD | 18.93% |
| 2010 | 676.72 Million USD | 13.45% |
| 2009 | 596.49 Million USD | -2.22% |
| 2008 | 610.03 Million USD | 17.42% |
| 2007 | 519.53 Million USD | -1.23% |
| 2006 | 525.97 Million USD | 5.87% |
| 2005 | 496.83 Million USD | 57.31% |
| 2004 | 315.83 Million USD | 19.09% |
| 2003 | 265.2 Million USD | 32.94% |
| 2002 | 199.49 Million USD | 30.07% |
| 2001 | 153.36 Million USD | 14.68% |
| 2000 | 133.73 Million USD | 20.59% |
| 1999 | 110.9 Million USD | 15.16% |
| 1998 | 96.3 Million USD | 36.4% |
| 1997 | 70.6 Million USD | 36.82% |
| 1996 | 51.6 Million USD | 28.68% |
| 1995 | 40.1 Million USD | 15.23% |
| 1994 | 34.8 Million USD | 2.65% |
| 1993 | 33.9 Million USD | 16.1% |
| 1992 | 29.2 Million USD | 48.98% |
| 1991 | 19.6 Million USD | -36.36% |
| 1990 | 30.8 Million USD | -33.04% |
| 1989 | 46 Million USD | -85.54% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 612.6 Million USD | 5.46% |
| 2024 Q2 | 580.9 Million USD | 1.29% |
| 2024 Q1 | 573.5 Million USD | -5.44% |
| 2023 Q4 | 606.5 Million USD | -0.57% |
| 2023 Q2 | 582.9 Million USD | 4.37% |
| 2023 Q3 | 610 Million USD | 4.65% |
| 2023 Q1 | 558.5 Million USD | 4.08% |
| 2023 FY | 2.35 Billion USD | 10.2% |
| 2022 Q3 | 552.1 Million USD | 3.68% |
| 2022 Q2 | 532.5 Million USD | 2.72% |
| 2022 Q4 | 536.6 Million USD | -2.81% |
| 2022 FY | 2.13 Billion USD | 9.4% |
| 2022 Q1 | 518.4 Million USD | 3.29% |
| 2021 Q1 | 450.7 Million USD | 6.3% |
| 2021 Q3 | 516.1 Million USD | 5.95% |
| 2021 Q4 | 501.9 Million USD | -2.75% |
| 2021 Q2 | 487.1 Million USD | 8.08% |
| 2021 FY | 1.95 Billion USD | 27.43% |
| 2020 FY | 1.53 Billion USD | -12.64% |
| 2020 Q1 | 426.5 Million USD | -6.26% |
| 2020 Q3 | 360.8 Million USD | 11.53% |
| 2020 Q4 | 424 Million USD | 17.52% |
| 2020 Q2 | 323.5 Million USD | -24.15% |
| 2019 Q4 | 455 Million USD | 0.95% |
| 2019 FY | 1.75 Billion USD | 7.63% |
| 2019 Q1 | 418.5 Million USD | -2.67% |
| 2019 Q2 | 432.6 Million USD | 3.37% |
| 2019 Q3 | 450.7 Million USD | 4.18% |
| 2018 Q3 | 426.8 Million USD | 5.51% |
| 2018 Q2 | 404.5 Million USD | 9.06% |
| 2018 Q1 | 370.9 Million USD | 4.95% |
| 2018 FY | 1.63 Billion USD | 19.51% |
| 2018 Q4 | 430 Million USD | 0.75% |
| 2017 Q3 | 356.2 Million USD | 3.58% |
| 2017 FY | 1.36 Billion USD | 16.43% |
| 2017 Q4 | 353.4 Million USD | -0.79% |
| 2017 Q1 | 312.4 Million USD | 5.55% |
| 2017 Q2 | 343.9 Million USD | 10.08% |
| 2016 Q3 | 316.64 Million USD | 6.08% |
| 2016 FY | 1.17 Billion USD | 9.61% |
| 2016 Q4 | 295.97 Million USD | -6.53% |
| 2016 Q1 | 261.96 Million USD | 3.42% |
| 2016 Q2 | 298.49 Million USD | 13.95% |
| 2015 Q3 | 272.88 Million USD | 1.93% |
| 2015 FY | 1.07 Billion USD | -1.95% |
| 2015 Q4 | 253.3 Million USD | -7.17% |
| 2015 Q2 | 267.71 Million USD | -3.12% |
| 2015 Q1 | 276.35 Million USD | -1.15% |
| 2014 Q2 | 268.49 Million USD | 2.12% |
| 2014 Q4 | 279.55 Million USD | -0.37% |
| 2014 Q1 | 262.92 Million USD | -0.35% |
| 2014 FY | 1.09 Billion USD | 6.31% |
| 2014 Q3 | 280.59 Million USD | 4.5% |
| 2013 Q3 | 268.27 Million USD | 5.55% |
| 2013 Q4 | 263.85 Million USD | -1.65% |
| 2013 Q1 | 240.49 Million USD | -4.85% |
| 2013 Q2 | 254.17 Million USD | 5.69% |
| 2013 FY | 1.02 Billion USD | 11.13% |
| 2012 Q1 | 210.45 Million USD | -5.89% |
| 2012 FY | 924.01 Million USD | 14.81% |
| 2012 Q4 | 252.76 Million USD | 5.28% |
| 2012 Q3 | 240.09 Million USD | 8.79% |
| 2012 Q2 | 220.69 Million USD | 4.87% |
| 2011 Q3 | 202.8 Million USD | 0.52% |
| 2011 FY | 804.8 Million USD | 18.93% |
| 2011 Q4 | 223.63 Million USD | 10.27% |
| 2011 Q2 | 201.76 Million USD | 14.24% |
| 2011 Q1 | 176.6 Million USD | -5.8% |
| 2010 FY | 676.72 Million USD | 13.45% |
| 2010 Q4 | 187.48 Million USD | 6.53% |
| 2010 Q3 | 175.98 Million USD | 7.64% |
| 2010 Q2 | 163.49 Million USD | 9.17% |
| 2010 Q1 | 149.76 Million USD | -5.75% |
| 2009 Q4 | 158.9 Million USD | 8.55% |
| 2009 Q1 | 142.13 Million USD | -12.29% |
| 2009 Q3 | 146.39 Million USD | -1.79% |
| 2009 FY | 596.49 Million USD | -2.22% |
| 2009 Q2 | 149.05 Million USD | 4.87% |
| 2008 Q3 | 155.09 Million USD | 3.39% |
| 2008 Q4 | 162.04 Million USD | 4.48% |
| 2008 Q1 | 142.88 Million USD | 21.87% |
| 2008 Q2 | 150 Million USD | 4.99% |
| 2008 FY | 610.03 Million USD | 17.42% |
| 2007 Q2 | 126.45 Million USD | -2.66% |
| 2007 FY | 519.53 Million USD | -1.23% |
| 2007 Q4 | 117.24 Million USD | -19.66% |
| 2007 Q3 | 145.92 Million USD | 15.4% |
| 2007 Q1 | 129.91 Million USD | 1.74% |
| 2006 Q3 | 137.76 Million USD | 4.87% |
| 2006 Q1 | 129.16 Million USD | -5.78% |
| 2006 FY | 525.97 Million USD | 5.87% |
| 2006 Q4 | 127.69 Million USD | -7.31% |
| 2006 Q2 | 131.36 Million USD | 1.7% |
| 2005 Q1 | 92.32 Million USD | 9.44% |
| 2005 Q3 | 136.61 Million USD | 4.44% |
| 2005 FY | 496.83 Million USD | 57.31% |
| 2005 Q2 | 130.8 Million USD | 41.69% |
| 2005 Q4 | 137.08 Million USD | 0.34% |
| 2004 Q4 | 84.35 Million USD | 1.47% |
| 2004 Q2 | 78.38 Million USD | 12.05% |
| 2004 Q1 | 69.95 Million USD | -6.45% |
| 2004 FY | 315.83 Million USD | 19.09% |
| 2004 Q3 | 83.13 Million USD | 6.06% |
| 2003 Q1 | 59.36 Million USD | -4.44% |
| 2003 FY | 265.2 Million USD | 32.94% |
| 2003 Q3 | 68.63 Million USD | 9.95% |
| 2003 Q2 | 62.42 Million USD | 5.14% |
| 2003 Q4 | 74.78 Million USD | 8.96% |
| 2002 Q1 | 37.48 Million USD | -20.78% |
| 2002 Q2 | 44.16 Million USD | 17.81% |
| 2002 Q4 | 62.12 Million USD | 11.5% |
| 2002 FY | 199.49 Million USD | 30.07% |
| 2002 Q3 | 55.71 Million USD | 26.16% |
| 2001 Q2 | 36.31 Million USD | 13.1% |
| 2001 Q3 | 37.62 Million USD | 3.61% |
| 2001 Q4 | 47.32 Million USD | 25.77% |
| 2001 FY | 153.36 Million USD | 14.68% |
| 2001 Q1 | 32.1 Million USD | -15.17% |
| 2000 Q3 | 36.77 Million USD | 13.2% |
| 2000 Q4 | 37.85 Million USD | 2.93% |
| 2000 Q1 | 25.6 Million USD | -25.8% |
| 2000 FY | 133.73 Million USD | 20.59% |
| 2000 Q2 | 32.48 Million USD | 26.89% |
| 1999 Q3 | 28.3 Million USD | 6.79% |
| 1999 FY | 110.9 Million USD | 15.16% |
| 1999 Q2 | 26.5 Million USD | 28.64% |
| 1999 Q1 | 20.6 Million USD | -17.93% |
| 1999 Q4 | 34.5 Million USD | 21.91% |
| 1998 Q1 | 18 Million USD | -22.41% |
| 1998 Q3 | 26.7 Million USD | 3.89% |
| 1998 Q4 | 25.1 Million USD | -5.99% |
| 1998 FY | 96.3 Million USD | 36.4% |
| 1998 Q2 | 25.7 Million USD | 42.78% |
| 1997 Q2 | 16.2 Million USD | 27.56% |
| 1997 Q1 | 12.7 Million USD | -25.73% |
| 1997 Q4 | 23.2 Million USD | 25.41% |
| 1997 FY | 70.6 Million USD | 36.82% |
| 1997 Q3 | 18.5 Million USD | 14.2% |
| 1996 Q4 | 17.1 Million USD | 27.61% |
| 1996 Q2 | 12.2 Million USD | 37.08% |
| 1996 Q1 | 8.9 Million USD | -20.54% |
| 1996 FY | 51.6 Million USD | 28.68% |
| 1996 Q3 | 13.4 Million USD | 9.84% |
| 1995 FY | 40.1 Million USD | 15.23% |
| 1995 Q4 | 11.2 Million USD | 6.67% |
| 1995 Q3 | 10.5 Million USD | 11.7% |
| 1995 Q1 | 8.9 Million USD | 20.27% |
| 1995 Q2 | 9.4 Million USD | 5.62% |
| 1994 Q2 | 9.3 Million USD | 9.41% |
| 1994 Q4 | 7.4 Million USD | -18.68% |
| 1994 Q3 | 9.1 Million USD | -2.15% |
| 1994 Q1 | 8.5 Million USD | -11.46% |
| 1994 FY | 34.8 Million USD | 2.65% |
| 1993 FY | 33.9 Million USD | 16.1% |
| 1993 Q1 | 7.6 Million USD | 322.22% |
| 1993 Q2 | 8 Million USD | 5.26% |
| 1993 Q3 | 9.1 Million USD | 13.75% |
| 1993 Q4 | 9.6 Million USD | 5.49% |
| 1992 Q4 | 1.8 Million USD | -87.84% |
| 1992 Q1 | 6 Million USD | 13.21% |
| 1992 FY | 29.2 Million USD | 48.98% |
| 1992 Q2 | 6.5 Million USD | 8.33% |
| 1992 Q3 | 14.8 Million USD | 127.69% |
| 1991 Q3 | 4.9 Million USD | -2.0% |
| 1991 Q1 | 4.3 Million USD | -67.67% |
| 1991 Q2 | 5 Million USD | 16.28% |
| 1991 Q4 | 5.3 Million USD | 8.16% |
| 1991 FY | 19.6 Million USD | -36.36% |
| 1990 Q2 | 13.2 Million USD | 28.16% |
| 1990 Q4 | 13.3 Million USD | 15.65% |
| 1990 Q1 | 10.3 Million USD | -23.13% |
| 1990 FY | 30.8 Million USD | -33.04% |
| 1990 Q3 | 11.5 Million USD | -12.88% |
| 1989 Q1 | 14.3 Million USD | -91.07% |
| 1989 FY | 46 Million USD | -85.54% |
| 1989 Q3 | 10.7 Million USD | -25.69% |
| 1989 Q4 | 13.4 Million USD | 25.23% |
| 1989 Q2 | 14.4 Million USD | 0.7% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 56.3 Million USD | -4087.728% |
| AngioDynamics, Inc. | 154.69 Million USD | -1424.196% |
| AtriCure, Inc. | 300.37 Million USD | -684.999% |
| Avinger, Inc. | 2 Million USD | -117618.422% |
| Azenta, Inc. | 263.14 Million USD | -796.063% |
| BioLife Solutions, Inc. | 46.75 Million USD | -4943.421% |
| Daxor Corporation | 1.1 Million USD | -213586.29% |
| Ekso Bionics Holdings, Inc. | 9.07 Million USD | -25870.922% |
| Femasys Inc. | 691.9 Thousand USD | -340685.748% |
| GlucoTrack, Inc. | -13 Thousand USD | 18137792.308% |
| Harvard Bioscience, Inc. | 60.86 Million USD | -3773.92% |
| Hologic, Inc. | 2.22 Billion USD | -5.84% |
| ICU Medical, Inc. | 739.87 Million USD | -218.69% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | 50.145% |
| KORU Medical Systems, Inc. | 16.7 Million USD | -14012.163% |
| LeMaitre Vascular, Inc. | 127.04 Million USD | -1755.898% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1976065.608% |
| Innovative Eyewear, Inc. | -119.32 Thousand USD | 1976065.608% |
| Masimo Corporation | 1 Billion USD | -134.968% |
| Microbot Medical Inc. | -106 Thousand USD | 2224533.962% |
| Meihua International Medical Technologies Co., Ltd. | 33.09 Million USD | -7024.641% |
| Merit Medical Systems, Inc. | 583.87 Million USD | -303.839% |
| Nephros, Inc. | 8.4 Million USD | -27953.54% |
| NovoCure Limited | 381.05 Million USD | -518.777% |
| NEXGEL, Inc. | 619 Thousand USD | -380820.84% |
| NEXGEL, Inc. | 619 Thousand USD | -380820.84% |
| Singular Genomics Systems, Inc. | -558 Thousand USD | 422662.724% |
| OraSure Technologies, Inc. | 179.42 Million USD | -1214.172% |
| Pro-Dex, Inc. | 14.55 Million USD | -16104.385% |
| Pulse Biosciences, Inc. | -1.2 Million USD | 195452.113% |
| Predictive Oncology Inc. | 1.14 Million USD | -205776.729% |
| Precision Optics Corporation, Inc. | 5.79 Million USD | -40569.036% |
| QuidelOrtho Corporation | 1.49 Billion USD | -57.782% |
| Repligen Corporation | 315.22 Million USD | -647.998% |
| Sanara MedTech Inc. | 57.13 Million USD | -4026.737% |
| STAAR Surgical Company | 252.65 Million USD | -833.264% |
| Sharps Technology, Inc. | -891.24 Thousand USD | 264661.604% |
| Utah Medical Products, Inc. | 30.03 Million USD | -7749.724% |
| DENTSPLY SIRONA Inc. | 2.08 Billion USD | -13.035% |
| Jin Medical International Ltd. | 6.78 Million USD | -34652.508% |